In this regard, CYP4F22 overexpression may function similar to the acid ceramidase gene (AC), overexpressed in multiple tumor types [56], and increasingly recognized as an important therapeutic target for pediatric brain tumors [57], acute myeloid leukemia [58], and melanoma [59, 60]. The gene discussed is CYP4F22; the disease is neoplasm.